Procter & Gamble: Baillie Gifford Sells 26,105 Shares; Brighton Jones Hikes 51.5%
Baillie Gifford & Co reduced its Procter & Gamble position by 2.8%, selling 26,105 shares in Q3 to hold 919,290 shares valued at $141.25 million. Brighton Jones LLC countered with a 51.5% stake increase to 40,068 shares worth $6.72 million, in moves reflecting 65.77% institutional ownership.
1. Institutional Trading Activity
In the third quarter, Baillie Gifford & Co. reduced its stake in Procter & Gamble by 2.8%, selling 26,105 shares and ending the period with 919,290 shares valued at $141.25 million. Other money managers made notable adjustments: Brighton Jones LLC increased its holding by 51.5%, adding 13,617 shares to reach 40,068 shares worth $6.72 million; Taylor Financial Group Inc. lifted its position by 10.6%, acquiring 277 shares to hold 2,891 shares valued at $493,000; Sivia Capital Partners LLC boosted its stake by 19.8%, adding 1,016 shares to hold 6,144 shares worth $979,000; Auxano Advisors LLC grew its ownership by 10.8%, buying 714 shares to total 7,315 shares valued at $1.17 million; and Perigon Wealth Management LLC edged up its position by 1.1%, adding 717 shares to hold 67,749 shares worth $10.79 million. Overall, institutional investors account for roughly two-thirds of outstanding shares.
2. Analyst Outlook and Price Targets
Following Procter & Gamble’s latest results, fourteen analysts maintain a Buy recommendation while seven have issued Hold ratings, yielding an average consensus rating of Moderate Buy. Barclays set a target of 155, TD Cowen reiterated its Buy endorsement, Morgan Stanley assigned a 175 objective, DBS Bank upgraded to Buy, and Raymond James trimmed its target to 175 with an Outperform rating. The average price objective across the coverage universe stands at approximately 167. Analysts cite the company’s resilient cash flow, consistent dividend growth and premiumization efforts in key markets as the drivers of upside potential.
3. Q2 Financial Performance and Guidance
For the fiscal second quarter, Procter & Gamble reported adjusted earnings per share of 1.88, beating the consensus forecast by 0.02, on revenue of 22.21 billion, narrowly below expectations by 0.15 billion. Net margin reached 19.3% while return on equity was 32.1%. Organic sales growth was modest at 1.5% year-over-year, reflecting strength in pricing partly offset by volume pressure in select categories. Management reiterated full-year EPS guidance in a range of 6.83 to 7.09, implying mid-single-digit growth on the top line and continued emphasis on share repurchases and dividend increases.
4. Dividend Declaration
The board declared a quarterly dividend of 1.0568 per share, payable in mid-February to shareholders of record at the close of business in late January. This distribution implies an annualized dividend of 4.23 and a payout ratio of approximately 62.7%, underscoring the company’s commitment to returning steady income to its shareholders.